Delivery Order SPE2DB24D2205-SPE2DB24FDVZA

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA). The $14,309.70 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024 with a completion date of September 10, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,369.92 and an ultimate completion date of December 5, 2024. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $31,753.82 and runs through December 31, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $26,692.61 and runs through May 31, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGE to the Defense Logistics Agency (DLA). The contract, valued at $76,105.80, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 6, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,956.68, was granted on July 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
This contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $32,421.63, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $75,679.50. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 15, 2024. The contract is not associated with any...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 13, 2024, with a ceiling value of $73,539.53 and a completion date of June 14, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award is for the delivery of Stelara 90 mg/ml syringes, a specialty medication, to the Defense Logistics Agency (DLA). The $11,174.35 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2022. The contract has an ultimate completion date of March 25, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVZA
    Delivery Order

This contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $45,502.62, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:56 AM